Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hongsong Bai"'
Autor:
Honglei Cui, Jie Wu, Gan Du, Linjun Hu, Xin Dong, Wang Qu, Hongsong Bai, Bingqing Shang, Ruiyang Xie, Hongzhe Shi, Youyan Guan, Xingang Bi, Changling Li, Jianhui Ma, Aiping Zhou, Jianzhong Shou
Publikováno v:
European Urology Open Science, Vol 70, Iss , Pp 109-115 (2024)
Background and objective: Systemic treatments involving immunotherapy-tyrosine kinase inhibitor (IO-TKI) combinations and TKI monotherapy have significantly improved outcomes for patients with metastatic clear-cell renal cell carcinoma (mccRCC). Howe
Externí odkaz:
https://doaj.org/article/ca4092eed5c54da7afd430d2cda674b6
Autor:
Ruiyang Xie, Bingqing Shang, Hongzhe Shi, Xingang Bi, Yan Song, Wang Qu, Hongsong Bai, Linjun Hu, Jie Wu, Honglei Cui, Gan Du, Lei Guo, Shan Zheng, Jianming Ying, Changling Li, Jianhui Ma, Aiping Zhou, Jianzhong Shou
Publikováno v:
Cancer Medicine, Vol 12, Iss 24, Pp 21807-21819 (2023)
Abstract Background The efficacy of systemic therapy regimens, such as immune checkpoint inhibitors and tyrosine kinase inhibitors (IO‐TKI) and targeted therapy, for metastatic clear cell renal cell carcinoma (ccRCC) remains unpredictable due to th
Externí odkaz:
https://doaj.org/article/c363eff574ea4eaa8124c12a23691c7e
Publikováno v:
BMC Urology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Objective To investigate the efficacy and complications of surgical treatment in patients with renal cell carcinoma aged ≥ 75 years. Methods From January 2009 to May 2019, we assessed 166 patients aged 75 years and older, who either had ra
Externí odkaz:
https://doaj.org/article/3d9be1baa73b424e8f9179d521b764dc
Publikováno v:
Journal of International Medical Research, Vol 50 (2022)
Primary female urethral carcinomas are uncommon and have a low morbidity rate. Most of these patients have advanced illness with high invasion and a poor prognosis. There is no standard treatment, and multimodal therapy is recommended. The use of rad
Externí odkaz:
https://doaj.org/article/5dbf923873054575a688b9d5465a00b6
Autor:
Zhenrong Yang, Hongsong Bai, Quanyou Wu, Linjun Hu, Guoliang Li, Defeng Kong, Qi Zhang, Duo Wan, Zhaoru Gu, Changyun Zhao, Kaitai Zhang, Wen Zhang, Jianzhong Shou
Publikováno v:
Transl Androl Urol
BACKGROUND: Whether circulating tumor cells (CTCs) with prostate-specific membrane antigen (PSMA) high expression was related to the metastatic progress in prostate cancer (PCa) remains explored. This study aimed to provide evidence to elucidate this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0a0ac59a7c03926e0d887cef2a53e30
https://doi.org/10.21037/tau-21-1140
https://doi.org/10.21037/tau-21-1140
Autor:
Shan Zheng, You-yan Guan, Kaopeng Guan, Hongsong Bai, Wen Zhang, Hongzhe Shi, Jianhui Ma, Yueping Liu, Changling Li, Weixing Jiang, Dong Wang, Zhilong Hu, Xingang Bi, Jin Zhang, Jun Tian, Linjun Hu, Yan Chen, Chuanzhen Cao, Jianzhong Shou, Aiping Zhou, Xiao-Li Feng, Zejun Xiao, Yexiong Li
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Reduced quality of life after cystectomy has made bladder preservation a popular research topic for muscle-invasive bladder cancer (MIBC). Previous research has indicated significant tumor downstaging after neoadjuvant chemotherapy (NAC). How
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e18c4a91f46994a792cf87b91265a1c
https://pubmed.ncbi.nlm.nih.gov/33592141
https://pubmed.ncbi.nlm.nih.gov/33592141
Autor:
Zhenrong Yang, Hongsong Bai, Linjun Hu, Defeng Kong, Guoliang Li, Changyun Zhao, Lin Feng, Shujun Cheng, Jianzhong Shou, Wen Zhang, Kaitai Zhang
Publikováno v:
EClinicalMedicine
Background Prostate-specific antigen (PSA) testing is limited in identifying prostate cancer (PCa) with modestly elevated PSA levels. Therefore, a robust method for the diagnosis of PCa is urgently needed. Methods A total of 203 men with a PSA level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29e96ef197e19812e494f815f0a6dc9e
https://doi.org/10.1016/j.eclinm.2021.101161
https://doi.org/10.1016/j.eclinm.2021.101161
Autor:
Dehu Lu, Dongdong Han, Nianzeng Xing, Dong Wang, Zejun Xiao, Yonghai Chen, Xingli Shan, Jun Tian, Hongsong Bai, Xingang Bi, Qinxin Zhao, Chengming Xie, Linjun Hu
Publikováno v:
Cancer Management and Research
Linjun Hu,1,* Qinxin Zhao,2,* Hongsong Bai,1 Chengming Xie,1 Xingli Shan,1 Dehu Lu,1 Yonghai Chen,1 Dongdong Han,1 Zejun Xiao,2 Jun Tian,2 Dong Wang,2 Xingang Bi,2 Nianzeng Xing2 1Department of Urology, Cancer Hospital of HuanXing Chaoyang District B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d8d24d3fdb880e2f4dc9abff50725b1
https://pubmed.ncbi.nlm.nih.gov/32606932
https://pubmed.ncbi.nlm.nih.gov/32606932
Autor:
Hongzhe Shi, Wen Zhang, Xingang Bi, Dong Wang, Zejun Xiao, Youyan Guan, Kaopeng Guan, Jun Tian, Hongsong Bai, Linjun Hu, Chuanzhen Cao, Weixing Jiang, Zhilong Hu, Jin Zhang, Yan Chen, Shan Zheng, Xiaoli Feng, Changling Li, Yexiong Li, Jianhui Ma
Publikováno v:
Cancer Research & Treatment; Oct2021, Vol. 53 Issue 4, p1156-1165, 10p
Autor:
Xueping Liu, Aiping Zhou, Xingang Bi, Jianhui Ma, Weixing Jiang, Jianzhong Shou, Linjun Hu, Chuanzhen Cao, Hongsong Bai
Publikováno v:
The Journal of Urology. 203:e1085
INTRODUCTION AND OBJECTIVE:Previous researches indicated Neoadjuvant Chemotherapy (NAC) achieved optimistic tumor degrading and bladder preservation rates in muscle-invasive bladder cancer (MIBC). ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1ef5e73b16497f1eaf545583d1810a6
https://doi.org/10.1097/ju.0000000000000953.07
https://doi.org/10.1097/ju.0000000000000953.07